510(k) Report

510(k) · Cleared

Cleared

IMMULITE 2000 Third Generation TSH, IMMULITE 2000 Free T4

K160647510(k) TraditionalCleared May 31, 201685-day reviewClass II21 CFR 862.1690

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Healthcare Diagnostics, Inc. · JLW Radioimmunoassay, Thyroid-Stimulating Hormone

Cleared on May 31, 2016 as substantially equivalent to K083373 (Siemens Healthcare Diagnostics, Inc., 2009) and 1 other predicate after an 85-day review. Its family tree reaches back 3 generations to 1990.

Decided
May 31, 2016
Review
85 days
Class
Class II
Product code
JLW
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K902336 (1990). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK902336 Ciba Corning Acs:180 Automated ChemiluminescenceCiba Corning Diagnostics Corp. · 1990
  2. 2 generations backK971418 Chiron Diagnostics Automated Chemiluminescence System (Asc) Centaur…Chiron Diagnostics Corp. · 1997 · Recalled
  3. 1 generation backK083373 Immulite 2000 Free T4Siemens Healthcare Diagnostics, Inc. · 2009
  4. This deviceK160647 IMMULITE 2000 Third Generation TSH, IMMULITE 2000 Free T4Siemens Healthcare Diagnostics, Inc. · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K902336Ciba Corning Acs:180 Automated ChemiluminescenceCiba Corning Diagnostics Corp.1990—
−2K971418Chiron Diagnostics Automated Chemiluminescence System (Asc) Centaur AnalyzerChiron Diagnostics Corp.19974
−1K083373Immulite 2000 Free T4Siemens Healthcare Diagnostics, Inc.2009—
0 (this device)K160647IMMULITE 2000 Third Generation TSH, IMMULITE 2000 Free T4Siemens Healthcare Diagnostics, Inc.2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
199710
FIG. 1 — Lineage of K160647, 1990–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JLW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JLW device

  1. #1 K251543 Atellica® IM TSH3-Ultra II (TSH3ULII)score 11.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K083373Immulite 2000 Free T4
Summary page 5
…Effectiveness 4. Predicate Device Information The Predicate Device for the modified IMMULITE 2000 Free T4 assay is the unmodified IMMULITE 2000 Free T4 assay (K083373). The Predicate Device for the modified IMMULITE 2000 Third Generation TSH assay is the unmodified IMMULITE 2000 Third Generation…
Siemens Healthcare Diagnostics, Inc.2009—
*K970227Immulite 2000 Automated Immunoassay Analyzer
Summary page 5
…assay (K083373). The Predicate Device for the modified IMMULITE 2000 Third Generation TSH assay is the unmodified IMMULITE 2000 Third Generation TSH assay (described in K970227). The modifications to the IMMULITE 2000 Free T4 and Third Generation TSH assays to add pediatric reference intervals to the Pack…
Dpc Cirrus199713

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 3 companies; a new generation was cleared every 7.3 years on median.
  • 3 of the 5 ancestors have a recall of any class.

How does its category compare?

All JLW devices

JLW Radioimmunoassay, Thyroid-Stimulating Hormone: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · JLW

1in 2025

2008: 52009: 22010: 12012: 12013: 12014: 12015: 32016: 32017: 42019: 12022: 12023: 12024: 22025: 12026 (partial year): 1
2007high 5 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JLW

194in 2017

2008: 143 days median2015: 142 days median2016: 238 days median2017: 194 days median
2007high 238 (2016) · low 142 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JLW

2in 2025

2007: 12010: 12011: 12012: 32016: 12018: 42019: 12020: 22024: 22025: 2
2007high 4 (2018) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JLW

103in 2025

2007: 192008: 102009: 412010: 342011: 1672012: 1442013: 1682014: 1552015: 2032016: 1832017: 2352018: 2492019: 2162020: 1452021: 1462022: 1372023: 1622024: 1692025: 103
2007high 249 (2018) · low 10 (2008)2025

MAUDE reports naming product code JLW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—119
20085143010
20092—041
20101—134
20110—1167
20121—3144
20131—0168
20141—0155
201531420203
201632381183
201741940235
20180—4249
20191—1216
20200—2145
20210—0146
20221—0137
20231—0162
20242—2169
20251—2103
20261—0—

What is it indicated for?

For in vitro diagnostic use with the IMMULITE® 2000 Systems Analyzers — for the quantitative measurement of thyrotropin (TSH) in serum. Measurements of thyroid stimulating hormone produced by the anterior pituitary are used in the diagnosis of thyroid or pituitary disorders.

For in vitro diagnostic use with the IMMULITE® 2000 Systems Analyzers — for the quantitative measurement of non-protein-bound thyroxine (free T4) in serum and heparinized plasma. Measurements of free thyroxine are used in the diagnosis and treatment of thyroid disease.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K160647: IMMULITE 2000 Third Generation TSH, IMMULITE 2000 Free T4.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K160647

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026